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Aims
In recent years, the role of gut flora in inflammatory
bowel diseases (IBD), including ulcerative colitis (UC)
and Crohn´s Disease (CD) has become focus of intense
research. The working hypothesis is that an altered
microbiota causes mucosal inflammation in a genetically
susceptible individual. Understanding the microbiota´s
role in the pathogenesis of the disease is essential for
new IBD treatments aimed in shifting the intestinal bac-
terial flora back to a physiological homeostasis, particu-
larly relevant for children not responding to
conventional therapy.
Methods
24 children, 6 with UC, 6 CD and 12 siblings without
disease pattern of IBD were included in this study. Chil-
dren were between 11-18 years and had no antibiotic
treatment for the last 3 month before fecal sample col-
lection. Frozen stool samples were delivered to EMBL,
Heidelberg, where further proceedings carried out,
including DNA extraction and next generation sequen-
cing (NGS) of the samples.
Results
The phylogenetic composition of 24 pediatric samples
were investigated and compared with the human Meta-
Hit project. The obtained data corroborated previous
findings from adult samples. In detail, our IBD cohort
displayed a lower bacterial diversity than the control
group without disease pattern of IBD. In addition, we
observed, that the enterotype distribution in children
with IBD were missing the enterotype 2.
Conclusion
We observed that children with IBD have changes in the
bacterial composition of feces with less bacterial diver-
sity. These observations support the rational of trans-
planting the fecal microbiota from a healthy donor into
an individual with IBD. The latter might restore the
healthy gut microbiota in the patient’s diseased colon,
leading to the resolution of symptoms, thus acting as a
novel therapeutic approach for children with IBD.
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